2101 COTTONTAIL LANE, SOMERSET, NJ
Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion
Voting Results of 2026 Annual General Meeting
Appoints Ingrid Zhang as Chief Executive Officer
Advancing a Robust, Differentiated Cell Therapy Pipeline
Proof 2 12 - Aug - 26 ABSTAIN AGAINST FOR ABSTAIN AGAINST FOR Res. 5 Res. 1 Res. 6 Res. 2 Res. 7 Res. 3 Res. 8 Res. 4
Reports Second Quarter 2026 Results and Recent Highlights
Material disclosure
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Exempt Offering of Securities
No filings found
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Registration Statement for Depositary Shares, Issued upon Effectiveness
Submission Upload
Correspondence